MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cognitive assessment in a Greek cohort of Multiple System Atrophy patients.

A. Bougea, C. Koros, A-M. Simitsi, N. Papagiannakis, E. Efthymiopoulou, I. Pachi, C. Chrysovitsanou, R. Antonelou, V. Constantinides, E. Kapaki, L. Stefanis (Athens, Greece)

Meeting: MDS Virtual Congress 2021

Abstract Number: 561

Keywords: Cognitive dysfunction, Multiple system atrophy(MSA): Clinical features

Category: Parkinsonism, Atypical: MSA

Objective: The aim of the present study was to assess cognitive dysfunction in a Multiple System Atrophy (MSA) cohort and possible differences between disorder subtypes MSA-parkinsonism (MSA-P) and MSA-cerebellar (MSA-C).

Background: It has been increasingly recognized that a variable degree of cognitive decline is present in most MSA cases, although frank dementia is rare at least in early disease stages. MSA patients exhibit executive dysfunction and selective visuospatial skills decline along with learning deficits.

Method: We conducted a retrospective study of MSA-P and MSA-C patients who attended Movement Disorders outpatient clinic from January 2020- January 2021. Patients underwent Montreal Cognitive Assessment scale (MoCA), Frontal Assessment Battery (FAB), semantic (animals) and phonemic (words starting from the Greek letter ‘’chi’’) verbal fluency evaluation and Digit Span (Forwards and Backwards) testing. Disease severity was assessed by Unified Parkinson’s Disease Rating scale part III. Comparison between MSA subtypes was performed using age, sex and education as covariates.

Results: A total of 28 MSA patients including 11 MSA-P subjects (age, 59.8±9.2 years; education, 11.1±4.7 years; UPDRSIII, 44.1± 21.1) and 17 MSA-C subjects (age, 64.6 ±6.7 years; education, 12.2±4.1 years; UPDRSIII, 29.1± 18) were enrolled. MSA patients scored 21.5±5.1 in the MoCA (Cut-off <26) and 12.4±3.8 in the FAB testing (Cut-off <12). Semantic verbal fluency (6±2.7, cut-off <13) and phonemic verbal fluency outcomes (5.4±2.3, cut-off <11) were low. Total Digit Span scoring was 15.6±7 with Digit Span Forwards and Backwards being 8.1±3.6 and 7.4±3.5 respectively. Regarding comparisons in cognitive assessment between MSA-P and MSA-C, no significant differences could be demonstrated for any score [MoCA (p=0.31), FAB (p=0.599), semantic fluency (p=0.289), phonemic fluency (p=0.251) and Total Digit Span (p=0.67)].

Conclusion: MSA patients exhibited decline in global cognitive scores like MoCA mainly reflecting deficits in attention/concentration and executive functions. Frontal function assessment score exemplified by FAB was marginal. Notably, striking low scores in semantic and phonemic fluencies were noticed. Moreover, despite literature data reporting differences between MSA-P and MSA-C in specific cognitive domains, we were unable to verify a distinct cognitive profile of each subtype.

To cite this abstract in AMA style:

A. Bougea, C. Koros, A-M. Simitsi, N. Papagiannakis, E. Efthymiopoulou, I. Pachi, C. Chrysovitsanou, R. Antonelou, V. Constantinides, E. Kapaki, L. Stefanis. Cognitive assessment in a Greek cohort of Multiple System Atrophy patients. [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/cognitive-assessment-in-a-greek-cohort-of-multiple-system-atrophy-patients/. Accessed July 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/cognitive-assessment-in-a-greek-cohort-of-multiple-system-atrophy-patients/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley